Abstract:Cytokines have been one of the recent focal points of immunological research in schizophrenia. The present study was to assess the serum levels of some of interleukins in schizophrenia and their relationships with the psychopathological parameters. Seventy physically healthy Chinese patients, who met DSM-III-R criteria for schizophrenia and who were drug-free for at least 2 weeks, were compared with 30 age- and sex-matched Chinese normal controls. The psychopathology of schizophrenia was assessed by the Positive and Negative Syndrome Scale (PANSS). Serum levels of IL-6 and IL-8 were measured by sandwich enzyme-linked immunosorbent assay (ELISA), and serum IL-2 level was assayed by radioimmunometric assay (RIA). Serum levels of IL-2, IL-6 and IL-8 were significantly elevated in patients with a chronic form of schizophrenia (all p<0.05). There was a significant inverse relationship between IL-2 level and the PANSS positive subscale P (r=-0.31, p=0.006) and a significant positive correlation between IL-8 level and PANSS negative subscale N (r=0.25, p=0.036) in schizophrenic patients. In control subjects, a significant and positive relationship between serum IL-2 and IL-6 (r=0.513, p=0.004) was noted, whereas, there was a significant and negative relationship between IL-2 and IL-8 in schizophrenic patients (r=-0.28, p=0.02). Our data confirms and supports the view that immune disturbance is involved in schizophrenia, which is compatible with the possibility that Chinese schizophrenic patients have an ongoing autoimmune process. This immune disturbance is related to the subgroup of schizophrenic patients with characteristic clinical variables. The dysfunction of interaction or inter-adjustment between different cytokines may exist in schizophrenic patients.

Plasma-soluble Interleukin-2 and Transferrin Receptor in Schizoprenia and Major Depression

Increased Plasma Concentrations of Interleukin-6, Soluble Interleukin-6, Soluble Interleukin-2 and Transferrin Receptor in Major Depression.

Plasma Soluble Interleukin-2-receptor in Depression: Relationships to Plasma Neopterin and Serum IL-2 Concentrations and HPA-axis Activity

Interleukin-2 and Interleukin-6 in Schizophrenia and Mania: Effects of Neuroleptics and Mood Stabilizers.

Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.

Lower Plasma CC16, a Natural Anti-Inflammatory Protein, and Increased Plasma Interleukin-1 Receptor Antagonist in Schizophrenia: Effects of Antipsychotic Drugs

Increased Serum IL-6 and IL-1 Receptor Antagonist Concentrations in Major Depression and Treatment Resistant Depression.

Elevated Interleukin-2, Interleukin-6 and Interleukin-8 Serum Levels in Neuroleptic-Free Schizophrenia: Association with Psychopathology

Plasma Levels of Interleukin-6, Interleukin-10, and Interleukin-1 Receptor Antagonist in Depression: Comparison Between the Acute State and after Remission

Psychoimmune Investigation in Obsessive-Compulsive Disorder - Assays of Plasma Transferrin, Il-2 and Il-6 Receptor, and Il-1-Beta and Il-6 Concentrations

Immune Disturbances During Major Depression: Upregulated Expression of Interleukin-2 Receptors

The Inflammatory Response System in Treatment-Resistant Schizophrenia: Increased Serum Interleukin-6

Immune-inflammatory Markers in Schizophrenia: Comparison to Normal Controls and Effects of Clozapine.

Plasma levels of IL-6, IL-10 and IL-12 and influencing factors in first-episode and neuroleptic-free schizophrenia patients

Plasma levels of IL-1Ra is associated with schizophrenia.

Increased Serum Interleukin-1-receptor-antagonist Concentrations in Major Depression

Indicators of Immune Activation in Major Depression.

The Plasma IL-18, MIP-1α, MCP-1, SDF-1 and Rantes in Patients with Majior Depression

Immunoendocrine Aspects of Major Depression

Increased Interleukin-2 Serum Levels Were Associated with Psychopathological Symptoms and Cognitive Deficits in Treatment-Resistant Schizophrenia.

Relationships Between Interleukin-6 Activity, Acute Phase Proteins, and Function of the Hypothalamic-Pituitary-adrenal Axis in Severe Depression.